Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
3D MEDICINES
3D MEDICINES (01244.HK): Envafolimab Moves to Regular Approval
Tags:
3D MEDICINES
01244.HK
Biopharma
2026-11-18
3D MEDICINES (01244.HK): 3D189 Hits REGAL Endpoint, Death Risk -41%
Tags:
3D MEDICINES
01244.HK
innovative drug
2026-11-18
3D MEDICINES (01244.HK): 3D189/GPS Phase 3 REGAL Hits Pre-specified 80 Events
Tags:
3D MEDICINES
01244.HK
R&D Progress
2026-10-29
3D MEDICINES (01244.HK): arbitration award against SELLAS Life Sciences fully received and executed, approximately HKD 7.98 million
Tags:
3D MEDICINES
01244.HK
Litigation
2026-08-18
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App